ATyr Pharma
ATyr Pharma[edit | edit source]
ATyr Pharma is a biotechnology company focused on the discovery and development of innovative medicines based on novel biological pathways. The company is headquartered in San Diego, California, and it specializes in the research of tRNA synthetase biology and its applications in treating various diseases.
History[edit | edit source]
ATyr Pharma was founded in 2005 by Dr. Paul Schimmel, a renowned scientist in the field of tRNA synthetase biology. The company was established to explore the therapeutic potential of proteins derived from tRNA synthetases, which are enzymes that play a crucial role in the translation of genetic information into proteins.
Research and Development[edit | edit source]
ATyr Pharma's research focuses on a class of proteins known as Physiocrines, which are derived from tRNA synthetases. These proteins have been found to have diverse biological functions, including roles in immune modulation, tissue regeneration, and inflammation. The company is investigating these proteins as potential treatments for a variety of diseases, including pulmonary disease, cancer, and autoimmune disorders.
Pipeline[edit | edit source]
The company's lead therapeutic candidate is ATYR1923, a fusion protein that targets the neuropilin-2 (NRP2) receptor. ATYR1923 is being developed for the treatment of interstitial lung diseases, including pulmonary sarcoidosis and other forms of fibrosis.
Collaborations[edit | edit source]
ATyr Pharma has established collaborations with several academic institutions and research organizations to advance its scientific discoveries. These partnerships aim to enhance the understanding of tRNA synthetase biology and accelerate the development of new therapeutic approaches.
Corporate Structure[edit | edit source]
The company is led by a team of experienced executives and scientists with expertise in biotechnology and drug development. ATyr Pharma is publicly traded on the NASDAQ stock exchange under the ticker symbol "LIFE."
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
